Home » Newsletters » BioWorld Asia

BioWorld Asia

Sep. 21, 1999

View Archived Issues

U.S. Official Blasts EU Leaders On Their Approach To Biotech

Privately Held CeNeS Proposes Reverse Merger With Core Group

Retraining Might Be Necessary To Supplement Cell Transplants

Arcoda Plans To Use Financing To Invest In Start-Up Companies

EuropaBio Decries Report On Control Of GM Seeds Industry

Companies Flock To Ginoptle, The 'Genetics Valley' of France

German Agency Founded To Focus Solely On Biotechnology

German Consortium Started To Link Genomics Information

Australian Researchers Plan Late-Stage Study For Warts

French Corn Producers Say Biotech Needed To Compete

XTL's Animal Model For HCV Licensed For Testing By Lilly

Evotec Cancels Initial Offering Due To Conditions In Germany

Vanguard Sings On Distributor In Europe For Migraine Drug

Transghne Starts First Study Of MVA-HPV Cancer Vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...